LRRK2 and Parkinson disease: Accordingly, a deeper understanding of the mechanisms by which LRRK2 regulates BMP and its impact on lysosomal function is needed to evaluate the therapeutic potential of LRRK2 kinase inhibition in PD and determine the utility of BMP and GSLs as lysosomal biomarkers of LRRK2 activity in the clinic.